|
1
|
Enzinger FM and Shiraki M: Extraskeletal
myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol.
3:421–435. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hinrichs SH, Jaramillo MA, Gumerlock PH,
Gardner MB, Lewis JP and Freeman AE: Myxoid chondrosarcoma with a
translocation involving chromosomes 9 and 22. Cancer Genet
Cytogenet. 14:219–226. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Turc-Carel C, Dal Cin P, Rao U, Karakousis
C and Sandberg AA: Recurrent breakpoints at 9q31 and 22q12.2 in
extraskeletal myxoid chondrosarcoma. Cancer Genet Cytogenet.
30:145–150. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bridge JA, Sanger WG and Neff JR:
Translocations involving chromosomes 2 and 13 in benign and
malignant cartilaginous neoplasms. Cancer Genet Cytogenet.
38:83–88. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Orndal C, Carlén B, Akerman M, et al:
Chromosomal abnormality t(9;22)(q22;q12) in an extraskeletal myxoid
chondrosarcoma characterized by fine needle aspiration cytology,
electron microscopy, immunohistochemistry and DNA flow cytometry.
Cytopathology. 2:261–270. 1991. View Article : Google Scholar
|
|
6
|
Bridge JA, Bhatia PS, Anderson JR and Neff
JR: Biologic and clinical significance of cytogenetic and molecular
cytogenetic abnormalities in benign and malignant cartilaginous
lesions. Cancer Genet Cytogenet. 69:79–90. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stenman G, Andersson H, Mandahl N,
Meis-Kindblom JM and Kindblom LG: Translocation t(9;22)(q22;q12) is
a primary cytogenetic abnormality in extraskeletal myxoid
chondrosarcoma. Int J Cancer. 62:398–340. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirabayashi Y, Ishida T, Yoshida MA, et
al: Translocation (9;22)(q22;q12). A recurrent chromosome
abnormality in extraskeletal myxoid chondrosarcoma. Cancer Genet
Cytogenet. 81:33–37. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sciot R, Dal Cin P, Fletcher C, et al:
t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal
myxoid chondrosarcoma: evaluation of three cases. Mod Pathol.
8:765–768. 1995.PubMed/NCBI
|
|
10
|
Rao UN, Surti U, Hoffner L, et al:
Extraskeletal and skeletal myxoid chondrosarcoma: A multiparameter
analysis of three cases including cytogenetic analysis and
fluorescence in situ hybridization. Mol Diagn. 1:99–107. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kilpatrick SE, Inwards CY, Fletcher CD,
Smith MA and Gitelis S: Myxoid chondrosarcoma (chordoid sarcoma) of
bone: a report of two cases and review of the literature. Cancer.
79:1903–1910. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Day SJ, Nelson M, Rosenthal H, Vergara GG
and Bridge JA: Der(16)t(1;16)(q21;q13) as a secondary structural
aberration in yet a third sarcoma, extraskeletal myxoid
chondrosarcoma. Genes Chromosomes Cancer. 20:425–427. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sjögren H, Meis-Kindblom JM, Kindblom LG,
Åman P and Stenman G: Fusion of the EWS-related gene TAF2N to TEC
in extraskeletal myxoid chondrosarcoma. Cancer Res. 59:5064–5067.
1999.PubMed/NCBI
|
|
14
|
Attwooll C, Tariq M, Harris M, Coyne JD,
Telford N and Varley JM: Identification of a novel fusion gene
involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation
in an extraskeletal myxoid chondrosarcoma. Oncogene. 18:7599–7601.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bjerkehagen B, Dietrich C, Reed W, et al:
Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and
identification of a new cytogenetic subgroup characterized by
t(9;17)(q22;q11). Virchows Arch. 435:524–530. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sjögren H, Wedell B, Meis-Kindblom J,
Kindblom LG and Stenman G: Fusion of the NH2-terminal domain of the
basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid
chondrosarcoma with translocation t(9;15)(q22;q21). Cancer Res.
60:6832–6835. 2000.PubMed/NCBI
|
|
17
|
Panagopoulos I, Mertens F, Isaksson M, et
al: Molecular genetic characterization of the EWS/CHN and RBP56/CHN
fusion genes in extraskeletal myxoid chondrosarcoma. Genes
Chromosomes Cancer. 35:340–52. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reid R, de Silva MV and Paterson L: Poorly
differentiated extraskeletal myxoid chondrosarcoma with
t(9;22)(q22;q11) translocation presenting initially as a solid
variant devoid of myxoid areas. Int J Surg Pathol. 11:137–141.
2003. View Article : Google Scholar
|
|
19
|
Sjögren H, Meis-Kindblom JM, Örndal C, et
al: Studies on the molecular pathogenesis of extraskeletal myxoid
chondrosarcoma: cytogenetic, molecular genetic, and cDNA microarray
analyses. Am J Pathol. 162:781–792. 2003.PubMed/NCBI
|
|
20
|
Domanski HA, Carlén B, Mertens F and
Akerman M: Extraskeletal myxoid chondrosarcoma with neuroendocrine
differentiation: a case report with fine-needle aspiration biopsy,
histopathology, electron microscopy, and cytogenetics. Ultrastruct
Pathol. 27:363–368. 2003. View Article : Google Scholar
|
|
21
|
Nilsson M, Meza-Zepeda LA, Mertens F,
Forus A, Myklebost O and Mandahl N: Amplification of chromosome 1
sequences in lipomatous tumors and other sarcomas. Int J Cancer.
109:363–369. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shaffer LG and Tommerup N: An
International System for Human Cytogenetic Nomenclature. S Karger;
Basel: 2005
|
|
23
|
Tsuneyoshi M, Enjoji M, Iwasaki H and
Shinohara N: Extraskeletal myxoid chondrosarcoma. A
clinicopathologic and electron microscopic study. Acta Pathol Jpn.
31:439–447. 1981.PubMed/NCBI
|
|
24
|
Meis-Kindblom JM, Bergh P, Gunterberg B
and Kindblom LG: Extraskeletal myxoid chondrosarcoma. A reappraisal
of its morphologic spectrum and prognostic factors based on 117
cases. Am J Surg Pathol. 23:636–650. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Saleh G, Evans HL, Ro JY and Ayala AG:
Extraskeletal myxoid chondrosarcoma. A clinicopathologic study of
ten patients with long-term follow-up. Cancer. 702:827–830.
1992.PubMed/NCBI
|
|
26
|
Hashimoto H, Daimaru Y and Enjoji M: S-100
protein distribution in liposarcoma. An immunoperoxidase study with
special reference to the distinction of liposarcoma from myxoid
malignant fibrous histiocytoma. Virchows Arch A Pathol Anat
Histopathol. 405:1–10. 1984. View Article : Google Scholar
|
|
27
|
Okamoto S, Hisaoka M, Ishida T, et al:
Extraskeletal myxoid chondrosarcoma: a clinicopathologic,
immunohistochemical, and molecular analysis of 18 cases. Hum
Pathol. 32:1116–1124. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hisaoka M, Ishida T, Imamura T and
Hashimoto H: TFG is a novel fusion partner of NOR1 in extraskeletal
myxoid chondrosarcoma. Genes Chromosomes Cancer. 40:325–328. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lucas DR and Heim S: Extraskeletal myxoid
chondrosarcoma. WHO Classification of Tumours, Pathology and
Genetics of Tumours of Soft Tissue and Bone. Fletcher CDM, Unni K
and Martens F: IARC Press; Lyon: pp. 213–215. 2002
|
|
30
|
Harris M, Coyne J, Tariq M, et al:
Extraskeletal myxoid chondrosarcoma with neuroendocrine
differentiation: a pathologic, cytogenetic, and molecular study of
a case with a novel translocation t(9;17)(q22;q11.2). Am J Surg
Pathol. 24:1020–1026. 2000. View Article : Google Scholar : PubMed/NCBI
|
